4th Quarter - Report
WILLIAMS AND JENSEN, PLLC for PHRMA
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures Initiative, H.R. 6. H.R. 2029.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| CHERYL LYNN JAEGER | — |
Medicare/Medicaid MMM
General education about policies impacting pharmaceutical development, approval and reimbursement. Non-interference. Rebates for Medicare Part D. Importation. 340B Drug Pricing Program. 21st Century Cures Initiative. H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015. H.R. 1021, Protecting the Integrity of Medicare Act. H.R. 2029
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| ANDREW JONES | Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.